@article {68418,
	title = {In situ cell-type-specific cell-surface proteomic profiling in mice.},
	journal = {Neuron},
	year = {2022},
	month = {10/2022},
	abstract = {<p>Cell-surface proteins (CSPs) mediate intercellular communication throughout the lives of multicellular organisms. However, there are no generalizable methods for quantitative CSP profiling in specific cell types in vertebrate tissues. Here, we present in situ cell-surface proteome extraction by extracellular labeling (iPEEL), a proximity labeling method in mice that enables spatiotemporally precise labeling of cell-surface proteomes in a cell-type-specific environment in native tissues for discovery proteomics. Applying iPEEL to developing and mature cerebellar Purkinje cells revealed differential enrichment in CSPs with post-translational protein processing and synaptic functions in the developing and mature cell-surface proteomes, respectively. A proteome-instructed in\&nbsp;vivo loss-of-function screen identified a critical, multifaceted role for Armh4 in Purkinje cell dendrite morphogenesis. Armh4 overexpression also disrupts dendrite morphogenesis; this effect requires its conserved cytoplasmic domain and is augmented by disrupting its endocytosis. Our results highlight the utility of CSP profiling in native mammalian tissues for identifying regulators of cell-surface signaling.</p>
},
	issn = {1097-4199},
	doi = {10.1016/j.neuron.2022.09.025},
	author = {Shuster, S Andrew and Li, Jiefu and Chon, URee and Sinantha-Hu, Miley C and Luginbuhl, David J and Udeshi, Namrata D and Carey, Dominique Kiki and Takeo, Yukari H and Xie, Qijing and Xu, Chuanyun and Mani, D R and Han, Shuo and Ting, Alice Y and Carr, Steven A and Luo, Liqun}
}
@article {2681,
	title = {Involvement of the ubiquitin-proteasome system in the early stages of wallerian degeneration.},
	journal = {Neuron},
	volume = {39},
	year = {2003},
	month = {2003 Jul 17},
	pages = {217-25},
	abstract = {<p>Local axon degeneration is a common pathological feature of many neurodegenerative diseases and peripheral neuropathies. While it is believed to operate with an apoptosis-independent molecular program, the underlying molecular mechanisms are largely unknown. In this study, we used the degeneration of transected axons, termed "Wallerian degeneration," as a model to examine the possible involvement of the ubiquitin proteasome system (UPS). Inhibiting UPS activity by both pharmacological and genetic means profoundly delays axon degeneration both in vitro and in vivo. In addition, we found that the fragmentation of microtubules is the earliest detectable change in axons undergoing Wallerian degeneration, which among other degenerative events, can be delayed by proteasome inhibitors. Interestingly, similar to transected axons, degeneration of axons from nerve growth factor (NGF)-deprived sympathetic neurons could also be suppressed by proteasome inhibitors. Our findings suggest a possibility that inhibiting UPS activity may serve to retard axon degeneration in pathological conditions.</p>
},
	keywords = {Amino Acids, Animal, Animals, Axons, Benzimidazoles, Blotting, Calpain, Cells, Chelating Agents, Cultured, Cysteine Endopeptidases, Cysteine Proteinase Inhibitors, Cytoskeleton, Disease Models, Drug Interactions, Egtazic Acid, Endopeptidases, Ganglia, Immunohistochemistry, Leupeptins, Microtubules, Multienzyme Complexes, Nerve Growth Factor, Newborn, Optic Nerve, Optic Nerve Injuries, Peptide Fragments, Proteasome Endopeptidase Complex, Rats, Sympathetic, Time Factors, Tubulin, Ubiquitin, Wallerian Degeneration, Western},
	issn = {0896-6273},
	author = {Zhai, Qiwei and Wang, Jing and Kim, Anna and Liu, Qing and Watts, Ryan and Hoopfer, Eric and Mitchison, Timothy and Luo, Liqun and He, Zhigang}
}
